The XPO1 overexpression and NF-κB expression may serve as potential biomarker associated with CRC proliferation and pathogenesis, therefore, further studies regarding the XPO1 overexpression prognostication in CRC patients may be recommended. Here, NFKB1 is linked to colorectal carcinoma.